Bartosz Piasecki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bartosz Piasecki has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Ewa Mojs
Department of Clinical Psychology, Poznań University of Medical Sciences, 60-812 Poznań, Poland
2 shared publications Maia Stanisławska-Kubiak
Department of Clinical Psychology, Poznań University of Medical Sciences, Poznań, Poland
1 shared publication- Michał Ziarko
Institute of Psychology, Adam Mickiewicz University in Poznań, Poznań, Poland
1 shared publication Wlodzimierz Samborski
Department of Physiotherapy, Rheumatology and Rehabilitation, Poznan University of Medical Sciences, 135/147 28 Czerwca 1956r. Street, 61-545 Poznan, Poland
1 shared publicationWojciech Strzelecki
Department of Clinical Psychology, Poznań University of Medical Sciences, Poznań, Poland
1 shared publication
Latest Publications
- 1 October 2017
- Published by SAGE Publications in Journal of Investigative Medicine
- Vol. 65 (7) , 1062-1067
Attention and Memory Impairments in Pediatric Patients with Cystic Fibrosis and Inflammatory Bowel Disease in Comparison to Healthy Controls
The main aim of the study was to analyze and compare attention and memory performance in pediatric patients with cystic fibrosis (CF), inflammatory bowel disease (IBD) and in healthy controls. 28 patients with CF, 30 patients with IBD and 30 healthy subjects took part in the study (all in age range of 7–17). All subjects were in intellectual norm. To analyze the functioning of attention, the d2 Test of Attention by Brickenkamp (d2 test) was applied. Memory performance was assessed using the Benton Visual Retention Test (BVRT) and the Trial of 10 words. The CF and IBD groups committed significantly more errors in the d2 test than the healthy controls. The CF group also had significantly higher fluctuation rates and received significantly lower scores in overall concentration performance than the control group. Patients with CF made more mistakes and had fewer correct memory projections in BVRT than the healthy controls. Patients with IBD committed significantly more errors in BVRT than the control group. Patients with CF and IBD also got significantly lower scores in the Trial of 10 words than the control group. Pediatric patients with CF and IBD performed more poorly than the healthy controls on attention and memory tests. More distinct cognitive impairments were observed in the CF group. Further research is needed to find the underlying mechanisms and clinical and/or functional significance of observed cognitive deficits.
- 1 October 2017
- Published by SAGE Publications in Journal of Investigative Medicine
- Vol. 65 (7) , 1062-1067
Attention and Memory Impairments in Pediatric Patients with Cystic Fibrosis and Inflammatory Bowel Disease in Comparison to Healthy Controls
The main aim of the study was to analyze and compare attention and memory performance in pediatric patients with cystic fibrosis (CF), inflammatory bowel disease (IBD) and in healthy controls. 28 patients with CF, 30 patients with IBD and 30 healthy subjects took part in the study (all in age range of 7–17). All subjects were in intellectual norm. To analyze the functioning of attention, the d2 Test of Attention by Brickenkamp (d2 test) was applied. Memory performance was assessed using the Benton Visual Retention Test (BVRT) and the Trial of 10 words. The CF and IBD groups committed significantly more errors in the d2 test than the healthy controls. The CF group also had significantly higher fluctuation rates and received significantly lower scores in overall concentration performance than the control group. Patients with CF made more mistakes and had fewer correct memory projections in BVRT than the healthy controls. Patients with IBD committed significantly more errors in BVRT than the control group. Patients with CF and IBD also got significantly lower scores in the Trial of 10 words than the control group. Pediatric patients with CF and IBD performed more poorly than the healthy controls on attention and memory tests. More distinct cognitive impairments were observed in the CF group. Further research is needed to find the underlying mechanisms and clinical and/or functional significance of observed cognitive deficits.
- Open Access
- 19 January 2014
- Published by Hindawi Limited in The Scientific World Journal
- Vol. 2014, 1-6
The Mediating Role of Dysfunctional Coping in the Relationship between Beliefs about the Disease and the Level of Depression in Patients with Rheumatoid Arthritis
Aim.Rheumatoid arthritis is one of the most severe chronic diseases. In many cases it leads to disability and results in a decreased quality of life and increased levels of anxiety and depression. The problem that needs to be addressed is the following: which mental processes lead to increased levels of depression in patients with rheumatoid arthritis?Methods.210 patients with rheumatoid arthritis hospitalized in rheumatology wards took part in the research. They filled in illness perception questionnaires (IPQ-R) and questionnaires for testing strategies of handling stress (Mini-COPE) and the level of depression (CES-D).Results.The observed correlation coefficients indicate that several elements of the perception of one’s disease moderately contribute to a high level of depression. Moreover, frequent use of dysfunctional coping strategies contributed to high levels of depression. Dysfunctional coping was moderately linked to depression.Conclusion.The conducted analyses confirmed the links between the beliefs about the disease and levels of depression and showed that the use of dysfunctional coping strategies mediates the relationship between the following elements of the representation of the disease:illness coherence, emotional representation, psychological attribution, risk factors,andthe level of depression.
- 19 January 2014
- Published by Hindawi Limited in The Scientific World Journal
- Vol. 2014, 1-6
Open AccessThe Mediating Role of Dysfunctional Coping in the Relationship between Beliefs about the Disease and the Level of Depression in Patients with Rheumatoid Arthritis
Aim.Rheumatoid arthritis is one of the most severe chronic diseases. In many cases it leads to disability and results in a decreased quality of life and increased levels of anxiety and depression. The problem that needs to be addressed is the following: which mental processes lead to increased levels of depression in patients with rheumatoid arthritis?Methods.210 patients with rheumatoid arthritis hospitalized in rheumatology wards took part in the research. They filled in illness perception questionnaires (IPQ-R) and questionnaires for testing strategies of handling stress (Mini-COPE) and the level of depression (CES-D).Results.The observed correlation coefficients indicate that several elements of the perception of one’s disease moderately contribute to a high level of depression. Moreover, frequent use of dysfunctional coping strategies contributed to high levels of depression. Dysfunctional coping was moderately linked to depression.Conclusion.The conducted analyses confirmed the links between the beliefs about the disease and levels of depression and showed that the use of dysfunctional coping strategies mediates the relationship between the following elements of the representation of the disease:illness coherence, emotional representation, psychological attribution, risk factors,andthe level of depression.